Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Sell
6,157
-1,129
-15% -$242K 0.03% 925
2026
Q1
$1.61M Buy
7,286
+6,318
+653% +$1.55M 0.03% 815
2025
Q4
$245K Buy
+968
New +$243K 0.01% 1402
2025
Q3
Sell
-9,105
Closed -$2.19M 2021
2025
Q2
$2.19M Buy
+9,105
New +$2.12M 0.05% 562
2025
Q1
Sell
-7,120
Closed -$1.46M 1591
2024
Q4
$1.46M Buy
7,120
+2,763
+63% +$606K 0.1% 296
2024
Q3
$1.06M Sell
4,357
-5
-0.1% -$1.17K 0.06% 428
2024
Q2
$958K Buy
+4,362
New +$948K 0.05% 511
2023
Q4
Sell
-2,535
Closed -$556K 1622
2023
Q3
$556K Buy
+2,535
New +$573K 0.05% 526
2022
Q4
Sell
-6,726
Closed -$1.12M 1332
2022
Q3
$1.12M Buy
+6,726
New +$1.37M 0.11% 277
2021
Q3
Sell
-3,695
Closed -$762K 895
2021
Q2
$762K Buy
+3,695
New +$744K 0.19% 153

Other funds holding STE

Y-Intercept (HK)'s STE Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Steris (STE) stake by 15% in Q2 2026, selling an estimated $242K and leaving 6,157 shares worth $1.3M. The position accounts for 0.03% of the portfolio, ranked #925.

Y-Intercept (HK) first reported a position in STE in Q2 2021 and has held it in 10 quarters since. The position peaked at $2.19M in Q2 2025. 144 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Y-Intercept (HK) held 6,157 shares of Steris worth $1.3M as of Q2 2026.
  • Y-Intercept (HK) sold 1,129 Steris shares in Q2 2026, an estimated $242K.
  • Steris made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #925 holding.
  • Y-Intercept (HK) first reported a position in Steris in Q2 2021 and has held it in 10 quarters since.
  • Y-Intercept (HK)'s Steris position peaked at $2.19M in Q2 2025.
  • 144 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.